Physician profile
Tracy N Javaherian
NPI 1477755361
$832.88
in general payments reported to CMS, 2019-2025
9 companies · $75.17 in 2025
The $75.17 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $59.93 · 2021: $155 · 2022: $37.65 · 2023: $56.06 · 2024: $74.57 · 2025: $75.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $221.19 | 2019-2025 | Abilify Asimtufii, Rexulti |
| Abbvie INC. | $205.53 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $150.17 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $97.20 | 2019-2021 | |
| Alkermes, INC. | $59.16 | 2024-2025 | Lybalvi, Aristada |
| Lundbeck LLC | $34.34 | 2019 | |
| Neurocrine Biosciences, INC. | $23.03 | 2025 | |
| Allergan, INC. | $22.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.70 | 2024 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Javaherian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.